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The Thesis entitled “SYNTHESIS OF PALMEROLIDE A, SACROLIDE 
A, AND ASPERGILLIDE D” has been divided into five chapters.  
CHAPTER I: This chapter describes the introduction, previous 
synthetic approaches and present work on the synthesis of the C1–
C15 fragment of Palmerolide A via protecting group dependent RCM 
reaction. 
CHAPTER II: This chapter describes the introduction, previous 
synthetic approaches and present work on formal total synthesis of 
Palmerolide A. 
CHAPTER III: This chapter includes introduction, Nozaki-Hiyama-
Kishi reaction as strategies of macrocyclizations for natural product 
synthesis and the total synthesis of Sacrolide A by following a Nozaki-
Hiyama-Kishi macrocyclization strategy. 
CHAPTER IV: This chapter covers introduction, employment of Shiina 
macrocyclization reaction as the pivotal step in natural product 
synthesis and present work on a second generation total synthesis of 
Sacrolide A. 
CHAPTER V: This chapter covers introduction, biological 
enhancement of isolated natural products and the current work on a 
total synthesis of the proposed structure of aspergillide D. 
CHAPTER I: Synthesis of the C1–C15 fragment of palmerolide A 
via protecting group dependent RCM reaction. 
Baker and co-workers isolated Palmerolide A (Figure 1), a complex 
polyunsaturated macrolide with an impressive molecular architecture 
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and biological profile, from the circumpolar marine tunicate Synoicum 
adareanum, which is commonly found in the shallow waters around 
Anvers Island on the Antarctic peninsula. This marine natural 
product found to exhibit excellent antitumor activity against a number 
of cell lines in the 60 cell panel of the National Cancer Institute (NCI). 
Specifically, it exhibits potent cytotoxicity against the melanoma cell 
lines UACC-62 (LC50 = 18 nM). Palmerolide A appears to act on 
melanoma cells through inhibition of vacuolar ATPase with an IC50 of 
2 nM. The remarkable 103 in vitro selectivity index for the melanoma 
cells over other most sensitive cell lines tested prompted further 
biological evaluation of the compound. The impressive biological 
properties of Palmerolide A, along with its extremely limited supply 
 
Figure 1. Structures of originally proposed (1) and revised (1a) 
Palmerolide A  
and for further structure-activity studies, prompted us to undertake 
its chemical synthesis. Considering all the previous synthetic reports, 
we envisioned a distinct retrosynthesis of fragment 3 (Scheme 1) that 
would take advantage of protecting group dependent ring-closing 
metathesis reaction developed in our group. 
As part of our ongoing research program on the synthesis of 
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biologically active natural and unnatural products using protecting 
group dependent ring-closing metathesis approach, we became 
interested in the synthesis of C1-C15 fragment of Palmerolide A. 
Retrosynthetic analysis: 
According to our retrosynthetic analysis of Palmerolide A (1a) shown 
in Scheme 1, macrolactone core 2 could be constructed through 
 
Scheme 1: Retrosynthetic analysis of Palmerolide A (1a). 
esterification of 3 and 4, followed by intramolecular Heck coupling. 
Fragment 3 could be obtained from the 13-membered macrolactone 5, 
which in turn could be prepared from 6 and 7 via coupling, followed 
by ring-closing metathesis reaction of the resulting diene compound. 
Both the coupling partners 6 and 7 could be prepared from 1,5 
pentane diol and 1,4 butane diol respectively. 
IV 
 
Synthesis of the acid fragment 6:  
The synthesis of acid fragment 6 was achieved following four synthetic 
steps from a known starting epoxide alcohol 9 as illustrated in 
Scheme 2. 
 
Scheme 2: Synthesis of the acid fragment 6. 
Scheme 2. Reagents and conditions: (a) (i) I2, PPh3, imidazole, THF, 0 
oC, 10 min, 92%; (ii) Activated Zn, NaI, EtOH, reflux, 2 h, 89%; (b) 
PMB-Br, NaH, THF, 0 oC, 4 h, 91%; (c) TBAF, THF, rt, 4 h, 94%; (d) (i) 
IBX, DMSO, THF, rt, 3 h; (ii) NaClO2, NaH2PO4, 2-methyl-2-butene, t-
BuOH, H2O, rt, 2 h, 92%. 
Synthesis of the alcohol fragment 7:  
Preparation of alcohol fragment 7 involved ten steps sequences from a  
 
Scheme 3: Synthesis of the alcohol fragment 7. 
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Scheme 3: Reagents and conditions: (a) AD-mix-α, MeSO2NH2, K2CO3, 
K3Fe(CN)6, t-BuOH:H2O (2:1), OSO4, 24 h, 0 oC, 89%; (b) 2,2-DMP, 
CH2Cl2, CSA, rt, 3 h, 92%; (c) (i) DIBAL-H,  CH2Cl2, 0 oC, 30 min; (ii) 
DMP, CH2Cl2, rt, 2 h; (iii) (PPh3-CH3)+Br- , NaHMDS, THF, −78 oC to 0 
oC, 4 h, 70% yield over three steps; (d) AcOH:H2O (3:2), 50 oC,  3 h, 
87%;    (e) PMBBr, NaH, THF, 0 oC, 4 h, 91%; (f) MOMCl, i-Pr2EtN, rt, 2 
h, 85%; (g) TBAF, THF, rt, 4 h, 95%. 
known starting α,β-unsaturated ester 14 via Sharpless asymmetric 
dihydroxylation, chemoselective deprotection of acetonide group in 
preference to TBDPS group and regioselective masking of secondary 
allylic alcohol (Scheme 3). Protecting group manipulation of compound 
19 afforded the requisite alcohol fragment 7 in quantitative yield. 
Unsuccessful attempt of the RCM reaction: 
The resulting diene synthesized from the both coupling partners was 
failed to produce the requisite 13-membered macrolactone due to 
  
Scheme 4: Formation of the coupling product 21a follοwed by 
unsuccessful attempt of RCM reaction (5a). 
Scheme 4: Reagents and conditions: (a) EDCI, DMAP, CH2Cl2, 0 oC to 




steric congestion due to bulky PMB-protecting group around the 
reacting centers which requires manipulation in protecting group. 
At this juncture, we thought of investigating the above reaction with a 
set of ring-closіng metathesis precursors by only changіng the 
protecting group of allylіc alcohol. The outcome of the reactions were  




PG PG1 PG2 Duration 







5a PMB PMB MOM 24  0 100 
5b Bn Bn MOM 24 0 100 
5c TBS TBS MOM 24 0 100 
5d MOM MOM MOM 12 70 20 
5e MOM MOM MOM 36 78 0 
5f H H MOM 12 82  
 
presented in Table 1. The excellent yield in case of 5f, could be due to 
forbearance of Grubbs’ catalyst wіth activated nucleophіle in the form 




Protecting group manipulation in the synthesis of acid fragment 
6b: 
The synthesis of modified acid fragment 6b involved the same 
synthetic sequences starting with MOM-protection of the allylic 
alcohol 10.  
 
Scheme 5: Synthesis of the acid fragment 6b. 
Scheme 5: Reagents and conditions: (a)  MOMCl, i-Pr2Et N, 2 h, rt, 
91%; (b) TBAF, THF, rt, 4 h, 93%; (c) (i) IBX, DMSO, THF, rt, 3 h; (ii) 
NaClO2, NaH2PO4, 2-methyl-2-butene, t-BuOH, H2O, rt, 2 h, 81% (over 
two steps). 
Protecting group manipulation in the synthesis of alcohol 
fragment 7b:  
The synthesis of the modified alcohol fragment 7b involved the same  
 
Scheme 6: Synthesis of the alcohol fragment 7b. 
Scheme 6: Reagents and conditions : (a) MOMCl, i-Pr2EtN, 2 h, 0 oC, 
85%;  (b) PMB-Br, NaH, THF, 0 oC, 6 h, 91%; (c) TBAF, THF, rt, 3 h, 
94%. 
synthetic sequences starting with regioselective protection of the 




Synthesis of the required C1-C15 fragment (3) of palmerolide A 
(1a):  
The synthesis of C1-C15 fragment 3 of Palmerolide A (1) has been 
achieved by following another four step sequences from acid 6 and 
alcohol 7 via EDCI mediated esterification, ring-closing metathesis 
followed by one carbon homologation (Scheme 7). 
 
Scheme 7: Synthesis of the C1–C15 fragment of Palmerolide A  
Scheme 7:  Reagents and Conditions: (a) EDCI, DMAP, CH2Cl2, 0 oC 
to r.t.,10 h, 84%; (b) Grubbs' 2nd generation catalyst, CH2Cl2, reflux, 
32 h, 75%; (c) DIBAL-H,  CH2Cl2, −78 oC, 15 min; (d) Ph3P=CHCO2Et, 
benzene, reflux, 2 h, 77% over two steps; (e) (i) DMP, CH2Cl2, NaHCO3, 
0 oC to rt, 2 h; (ii) (PPh3-CH3)+Br-, nBuLi, THF, −78 oC to 0 oC, 3 h, 
78% over two steps. 
CHAPTER II: Formal total synthesis of Palmerolide A 
Baker and co-workers in 2006 reported the isolation and structural 
determination of Palmerolide A (Figure 1), the most prominent 
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member of Palmerolide group, which is mainly due to its cytotoxicity, 
from the Antarctic marine tunicate Synoicum adareanum. Palmerolide 
A is a complex natural product comprising of a side chain containing 
an enamide, a 1,3-diene system, a carbamate moiety, five stereogenic 
centers, seven unsaturations with E-configuration and 20-membered 
macrolide ring. This natural product demonstrated extraordinary 
cytotoxic activity against the melanoma cell lines UACC-62 (LC50 = 18 
nM) by inhibiting the proliferation of vacuolar ATPase with an IC50 of 2 
nM. The remarkable 103 in vitro selectivity index for the melanoma 
cell lines prompted further biological evaluation of the compound. 
These findings coupled with the scarce natural abundance of 
Palmerolide A generated considerable interest in its chemical 
synthesis.  
Considering all these synthetic reports, a distinct retrosynthesis of 
macrolactone core 30 including intramolecular Heck coupling, 
intermolecular Yamaguchi reaction, protecting group dependent ring-
closing metathesis reaction for the building of fragment 31, 
regioselective reductive opening of epoxide by Me3Al and Takai 
olefination on methyl ketone for the construction of C16-C23 fragment 
was envisioned.  
Retrosynthetic analysis: 
According to the retrosynthetic analysis of Palmerolide A (1a) as 
shown in Scheme 1, macrolactone core 30 could be constructed 
through esterification of 31 and 4, followed by intramolecular Heck 
coupling. Fragment 31 could be obtained from the 13-membered 
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macrolactone 27, which in turn could be prepared from 6b and 7b via 
coupling, followed by ring-closing metathesis reaction of the resulting 
diene compound. 
 
Scheme 8: Retrosynthetic analysis of Palmerolide A. 
Synthesis of major acid fragment of Palmerolide A: 
The synthesis of the major acid fragment 31 of Palmerolide A (1a) has 
been achieved by following another five steps sequences from acid 6b 
and alcohol 7b via EDCI mediated esterification, ring-closing 
metathesis and Wittig olefination. Synthesis of both the coupling 
partners acid 6b and alcohol 7b involved the same synthetic 
sequence, which was earlier discussed in chapter 1. The ester 
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functionality of 3 was saponified to produce the required acid 31, 
which completes the synthesis of major acid fragment (Scheme 9).  
Synthesis of the acid fragment (6b) 
 
 Synthesis of the alcohol fragment (7b) 
 
Synthesis of major acid fragment of palmerolide A (31)  
  
Scheme 9: Synthesis of the major acid fragment 31. 
Scheme 9: Reagents and conditions: (a) LiOH, THF:H2O (3:2), reflux, 
15 h, 95%. 
Synthesis of the major alcohol fragment of Palmerolide A: 
The major alcohol fragment 4 has been synthesized from a known 
compound 33 in 14 steps via Sharpless asymmetric epoxidation, 
regioselective reductive opening of epoxide in presence of Me3Al and 
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introduction of trans-vinyl iodide under Takai olefination (Scheme 10). 
 
Scheme 10: Synthesis of the major alcohol fragment 4. 
Scheme 10: Reagents and conditions: (a) Ni(OAc)2, NaBH4, 
NH2(CH2)2NH2, EtOH, H2, 2 h, 89%; (b) Ti(OiPr)4, (+)DIPT, TBHP, MS (4 
Ǻ), CH2Cl2, 24 h, −23 oC, 96%; (c) (i) (COCl)2, DMSO, Et3N, CH2Cl2, 
−78 oC, 4 h; (ii) PPh3=C(CH3)CO2Et, benzene, 90 oC, 3 h, 68% over two 
steps; (d) Me3Al, H2O, CH2Cl2, −40 oC, rt, 3 h, 91%; (e) DIBAL-H, 
CH2Cl2, −78 oC, 1 h, 93%; (f) TBSOTf, 2,6-lutidine, CH2Cl2, 30 min, 0 
oC, 93%; (g) DDQ, CH2Cl2:H2O (19:1), pH = 7 buffer, rt, 1 h, 92%; (h) (i) 
DMP, CH2Cl2, 0 oC-r.t., 2 h; (ii) MeMgBr, THF, 0 oC, 2 h, 79% yield 
over two steps; (i) DMP, CH2Cl2, 0 oC-r.t., 3 h, 91%; (j) CHI3, CrCl2, 
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THF, rt, >3:2 (E:Z), 10 h, 78%; (k) TBAF, THF, rt, 6 h, 89%; (l) TBSCl, 
imidazole, CH2Cl2, 0 oC, 1 h, 92%. 
Completion of the formal total synthesis of Palmerolide A. 
The formal total synthesis of Palmerolide A (1a) has been 
accomplished by following four-step sequences from acid 31 and 
alcohol 4 via intermolecular Yamaguchi esterification and Heck 
macrocyclization (Scheme 11).  
 
Scheme 11: Completion of the formal total synthesis of Palmerolide A. 
Scheme 11:  Reagents and conditions: (a) 2,4,6-Cl3H2COCl, Et3N, 
DMAP, toluene, 4 h, 93%; (b) DDQ, CH2Cl2:H2O (19:1), pH = 7 buffer, 
r.t., 30 min, 95%; (c) TBSOTf, 2,6-lutidine, CH2Cl2, 0 oC, 1 h, 96%; (d) 
Pd(OAc)2, K2CO3, DMF, 80 oC, 2 h, 60%. 
XIV 
 
CHAPTER III: Total Synthesis of Sacrolide A by Following a 
Nozaki-Hiyama-Kishi Macrocyclization Strategy. 
Sacrolide A (Figure 2), a new cytotoxic oxylipin 14-membered 
macrolide was isolated from the cyanobacterium Aphanothece sacrum 
by Igarashi and co-workers in 2014. Aphanothece sacrum is an 
endemic species, which is a grandeur ingredient for Japanese cuisine 
found in the Aso water system in the Kyushu District, Japan. Edible 
cyanobacteria A. Sacrum, which is a bioactive secondary metabolite 
possesses a wide antimicrobial spectrum and cytotoxicity. Compound 
48 was shown to be a potent inhibitor for the growth of some species 
of Gram-positive bacteria, yeast Saccharomyces cerevisiae and fungus 
Penicillium chrysogenum. It also exhibits cytotoxic activity against 3Y1 
rat fibroblasts with the GI50 4.5 μM. Sacrolide A (48) contains two 
unsaturations that include vinylic ketone, a cis-configured double 
bond in the side chain, and two chiral centers. Sacrolide A, which was 
blessed with impressive molecular structure and interesting biological  
 
Figure 2. Structure of sacrolide A (1). 
profile coupled with the scarce natural abundance of this macrolide 
(Class IA endangered species by the Ministry of Environment) has 
prompted us to undertake its chemical synthesis. Herein, we report 
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the first enantioselective total synthesis of Sacrolide A.  
Many natural products, including macrolides with different ring size 
have been synthesized by employing intramolecular NHK coupling as 
the key macrocyclization step. Considering all these synthetic reports, 
we envisioned a distinct retrosynthesis of sacrolide A that would 
validate NHK macrocyclization strategy for 14 membered macrolide. 
Retrosynthetic analysis:  
According to our retrosynthetic analysis of sacrolide A (48) as shown 
in Scheme 12, macrolactone core of 48 could be constructed through 
yamaguchi esterification of 50 and 51, followed by intramolecular 
Nozaki-Hiyama-Kishi reaction on vinylic iodide 49. Accordingly, 
Alcohol fragment 51 would also be achieved by 
 
Scheme 12: Retrosynthetic analysis of Sacrolide A 
a short sequence involving Jacobsen’s hydrolytic kinetic resolution of  
PMB-protected glycidol (±) to establish the stereogenic centers at C-13. 
The acid fragment 50 could be obtained from the 1,9-nonane diol 
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through Sharpless asymmetric epoxidation followed by 
hydrozirconation-iodination sequence as the key steps. We report here 
the first enantioselective total synthesis of Sacrolide A highlighted by 
an intramolecular NHK coupling reaction. 
Synthesis of the acid fragment 3: 
The synthesis of the acid fragment 6 was achieved by following nine 
synthetic sequences from the commercially available 1,9-nonane diol  
 
Scheme 13: Synthesis of acid frgament 50 
Scheme 13: Reagents and conditions: (a) (i) CCl4, PPh3, NaHCO3, 
THF, reflux, 6 h, 92%; (ii) nBuLi, THF, −78 to 0 oC, 2 h, 86%; (b) 
Cp2ZrCl2, DIBAL-H, THF, 0 oC, 1 h, then I2, THF, −78 to 0 oC, 30 min, 
91%; (c) TBSCl, imidazole DMAP, CH2Cl2, 0 oC-r.t., 93 %; (d) DDQ, 
CH2Cl2:H2O (19:1), pH = 7 buffer, r.t., 92%; (e) (i) (COCl)2, DMSO, 
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Et3N, CH2Cl2, -78 oC; (ii) NaClO2, NaH2PO4, 2-methyl-2-butene, t-
BuOH, H2O, rt, 2 h, 78% over two steps. 
5 via Sharpless asymmetric epoxidation, n-BuLi induced opening of 
epoxy chloro compound followed by employment of hydrozirconation-
iodination sequence on the resulting propargylic alcohol 8 illustrated 
in Scheme 13. 
Synthesis of alcohol fragment 51: 
Preparation of alcohol fragment 51 involved two step sequences from a 
known starting chiral PMB glycidol 53 via Jacobsen’s hydrolytic 
kinetic resolution and incorporation of cis-geometry in the side chain 
with triphenylphosphonium salt of n-propylbromide in the presence of 
nBuLi under Wittig reaction condition (Scheme 14).  
 
Scheme 14: Synthesis of alcohol frgament 51 
Scheme 14: Reagents and conditions: (a) (i)NaIO4, OsO4, 2,6-lutidine, 
1,4-dioxane–H2O (3:1), 0 °C, 3 h, 87%; (ii) (PPh3-CH2CH2CH3)+Br- , 
nBuLi, THF, −78 oC to 0 oC, 2 h, 72% yield over two steps (b) TBAF, 
THF, rt, 4 h, 90%. 
Completion of the total synthesis of Sacrolide A (48): The total 
synthesis of sacrolide A (48) has been achieved by following six step 
sequences from acid 50 and alcohol 51 via Yamaguchi esterification 
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and intramolecular Nozaki-Hiyama-Kishi reaction (Scheme 15).  
 
Scheme 15: Completion of the total synthesis sacrolide A (48). 
Scheme 15: Reagents and conditions: (a) 2,4,6-Cl3C6H2COCl, Et3N, 
DMAP, toluene, 89%; (b) DDQ, CH2Cl2:H2O (19:1), pH = 7 buffer, r.t., 
92%; (c) DMP, CH2Cl2, NaHCO3, 0 oC to rt, 2 h; (d) NiCl2,CrCl2, DMSO, 
r.t., 6 h, 52% over two steps; (e) DMP, CH2Cl2, NaHCO3, 0 oC to rt, 2 h, 
78%; (f) HF.Py, THF, r.t., 7 h, 81%. 
CHAPTER IV: A second generation total synthesis of sacrolide A 
In 2014, Igarashi and co-workers reported the isolation of 14-
membered oxylipin-derived cytotoxic macrolide from the 
cyanobacterium Aphanothece sacrum. Aphanothece sacrum, a luxury 
ingredient for Japanese cuisine exist as a macroscopic gelatinous 
floating colonies in fresh water discovered in the Kyushu District, 
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Japan. The absolute structures were confirmed through chiral 
anisotropy analysis and conformational analysis of different ring-
opened derivatives through NOESY and HSQC experiments. 
Compound 48 possesses a wide antimicrobial spectrum, a potent 
inhibitor for the growth of few species of Gram-positive bacteria, yeast 
Saccharomyces cerevisiae and fungus Penicillium chrysogenum and 
cytotoxic activity against 3Y1 rat fibroblasts with GI50 4.5 μM. 
Sacrolide A (48) embedded with α,β-unsaturated ketone, a cis-
configured double bond in the side chain, and two chiral centers. 
Barred from overharvesting and water pollution due to its economical 
value coupled with increasing urbanization make Sacrolide A, a scarce 
source which could be procured by it’s synthesis. Impressive 
molecular structure with sensitive functionality and modification in 
structure-activity relationship with biological activation of suitable 
derivatives in order to enhance biological profile coupled with the 
limited availability of large quantities of Sacrolide A (Class IA 
endangered species by the Ministry of Environment) has prompted us 
to undertake its chemical synthesis.  
Several methods were addressed for esterification/lactonization 
strategy towards the formation of macrolide core of natural products 
on the basis of numerous acid activating reagent in presence of 
different acid and base catalyst to make the activated ester better 
electrophile for the alcohol. Yamaguchi and Shiina macrocyclization 
are the well-known (versatile) methods where high concentration of 
DMAP as acylation catalyst is required without which, reactions do 
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not work. High dose of 4-(dimethylamino) pyridine was problematic for 
base-sensitive substrates by inducting isomerization/epimerization. 
To circumvent the above problem, macrolactonization developed by 
Kita constitutes an effective method for unsaturated acids and 
enolizable alcohol via ruthenium-proton two stage esterification in 
presence of catalytic amount of acid catalyst. Barry M. Trost examined 
a set of precursors under acid catalyzed macrolactonization showing 
apt method for 14 and more members lactone. Considering all these 
synthetic reports, we envisaged a distinct retrosynthesis of Sacrolide A 
that would validate Kita macrocyclization strategy for 14-membered 
macrolide. 
Retrosynthetic analysis:  
According to our retrosynthetic analysis of Sacrolide A (48) as shown 
 
Scheme 16: Retrosynthetic analysis of sacrolide A (48) 
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in Scheme 16, macrolactone core of 48 could be constructed through 
nucleophilic addition of lithiated MOM-protected propargylic moiety to 
aldehyde 68, followed by acid-catalyzed Kita macrocyclization of seco-
acid 65. Accordingly, alcohol fragment 67 would also be achieved by a 
short sequence involving Jacobsen’s hydrolytic kinetic resolution of 
PMB-protected glycidol  (±) 53 to establish the stereogenic center at C-
13. The alkyne moiety 66 could be obtained from the 1,9-nonane diol 
(52) through Sharpless asymmetric epoxidation followed by base-
induced opening of the epoxide ring as key steps.  
Synthesis of the MOM-protected propargylic alcohol fragment 66: 
  
Scheme 17: Synthesis of the MOM-protected propargylic alcohol 
fragment 66. 
Scheme 17: Reagents and conditions: (a) (i) CCl4, PPh3, NaHCO3, 
THF, reflux, 6 h, 92%; (ii) nBuLi, THF, −78 to 0 oC, 2 h, 86%; (b) 
MOMCl, i-Pr2EtN, 2 h, 0 oC, 85%. 
Preparation of MOM-protected propargylic alcohol fragment 66 
involved three step sequences from a known starting epoxy alcohol 54 
via Sharpless asymmetric epoxidation, formation of propargylic alchol 
55 following Yadav’s protocol and protection of resulting secondary 




Synthesis of aldehyde fragment 2: 
Preparation of aldehyde fragment 68 involved three step sequences 
from a known starting chiral PMB glycidol 53 following Jacobsen’s 
hydrolytic kinetic resolution and Wittig reaction with 
triphenylphosphonium salt of n-propylbromide to introduce cis-
geometry in the side chain. 
 
Scheme 18: Synthesis of aldehyde fragment 7. 
Scheme 18: Reagents and conditions: (a) (i) NaIO4, OsO4, 2,6-lutidine, 
1,4-dioxane–H2O (3:1), 0 °C, 3 h; (ii) (PPh3-CH2CH2CH3)+Br- , n-BuLi, 
THF, −78 oC to 0 oC, 2 h, 72% yield over two steps; (b) DDQ, 
CH2Cl2:H2O (19:1), pH = 7 buffer, rt, 1 h, 92%; (c) (COCl)2, DMSO, 
Et3N, CH2Cl2, −78 oC, 4 h, 87%. 
Completion of the second generation synthesis of Sacrolide A: 
The total synthesis of Sacrolide A (48) has been achieved by following 
seven step sequences from both the coupling partners 67 and 68 via 
nucleophilic addition of lithiated MOM-protected propargylic moiety to 
aldehyde 68, Red-Al mediated controlled reduction of internal triple 




Scheme 19: Completion of the second generation total synthesis 
sacrolide A. 
Scheme 19: Reagents and conditions: (a) ) n-BuLi, HMPA, dry THF, -
78 oC, 1.5 h, 74%; (b) Red-Al, THF, 4 h, -20 oC, 76%; (c) DDQ, 
CH2Cl2:H2O (19:1), pH = 7 buffer, r.t., 92%; (d) (i) DMP, CH2Cl2, 
NaHCO3, 0 oC to rt, 2 h; (ii) NaClO2, NaH2PO4, 2-methyl-2-butene, t-
BuOH, H2O, r.t., 2 h, 81% over two steps (e) HF.Py, THF, r.t., 8 h, 
76%; (f) EtOCCH, [{RuCl2(p-cymene)}2], toluene, 0 oC to r.t., CSA, 50 
oC, 35%; (g) TFA, CH2Cl2, r.t., 5 h, 82%. 
macrocyclization of seco-acid 65 (Scheme 19). Macrolactonization of 
the resulting seco-acid 65 was first attempted under Shiina’s protocol 
by treating with 2-methyl-6-nitrobenzoic anhydride (MNBA) as an acid 
activating reagent in presence of DMAP led to 13 in quantitative yield 
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(82%) but poor stereoselectivities (approximately 65:35). At thіs 
juncture, we envisioned that acіd catalyzed macrolactonization of 
seco-acіd 82 under kita protocol39 as basіc acylating catalyst DMAP 
іnducted isomerisation. 
CHAPTER V: Total synthesis of the proposed structure of 
aspergillide D.  
Aspergillide D (74) (Figure 3), a 16-membered macrolide was isolated 
along with two polyketones, (R)-semivioxanthin (75), (R)-
semixanthomegnin (76) and four alkaloids, 5-(1H-indol-3-ylmethyl)-
imidazolidine-2,4-dionemarine (77), 9α,14-dihydroxy-6β-p-nitro-
benzoylcinnamolide (78), 7α,14-dihydroxy-6β-p-nitro-
benzoylconfertifolin (79), azonazine (80) from marine-derived fungus 
Aspergillus sp. SCSGAF 0076. Elucidation of the structure of 
aspergillide D was based on NMR with E-configuration of double bond 
from 1H nmr (J = 16Hz), relative configuration by NOESY spectrum 
and mass spectra (HRESIMS: m/z 323.1828 [M + Na]+). 14-membered 
and 16-membered macrolides isolated from fungi and bacteria 
generally displayed antibacterial activity but this new macrolide 
exhibited no antibacterial activity against both Escherichia coli and 
Staphylococcus aureus. Compounds 78 and 79 showed antiviral 
activity against H1N1 and H3N2, with IC50 values of 7.4 and 4.3 μM 
for 78 and IC50 values of 36.0 and 12.0 μM for 79 respectively. The 
structure-activity relationships revealed that the combination of 
lactone and side chain parts is important to the strong biological 
activity of natural products. Much of the structure-activity studies on 
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 such molecules is gathered on the aglycons without attention to the  
 
Figure 3. Structure of Aspergillide D (74) and different polyketones 
and alkaloids. 
corresponding carbohydrate components. Here in we describe the total 
synthesis of aspergillide D, a 16-membered macrolactone following 
Shiina macrolactonization as the key step. The biologіcal activities of 
aspergillіde D has not been extensіvely explored, presumably due to 
the scarce natural abundance whіch can be recouped by total 
synthesіs for further biological evaluatіon. The quest for improvement 
of biologіcal significance of aspergillіde D with further structure-
activіty studies, along wіth its extremely limіted supply, prompted us 
to undertake іts chemical synthesis. 
Retrosynthetic analysis: According to the retrosynthetic analysis of 
aspergillide D (74) as shown in Scheme 20, the macrolactone core of 
aspergillide D could be synthesized from seco-acid 82 via 




Scheme 20: Retrosynthetic analysis of aspergillide D (74). 
from α,β-unsaturated ester 98 through two carbon homologation on 
the corresponding lactol of the 14-membered macrolactone 97 with 
controlled DIBAL-H reduction. 14-membered saturated macrolactone 
97 could be constructed by ring-closing metathesis reaction of the 
resulting diene compound followed by PtO2 reduction wich in turn  
could be prepared from 84 and 85 via Yamaguchi coupling. Acid 
fragment 84 would be obtained from lactol 88 by Wittig olefination, 
which in turn could be prepared from D-ribose by following the 
previous report whereas alcohol fragment 85 could be acessed from 
1,8-octane diol 87 through Sharpless asymmetric resolution. 
Synthesis of the acid fragment 84: The synthesis of acid fragment 
84 was achieved following two synthetic sequences from a known 
starting material 2,3-acetonide 88 via Wittig olefination followed by 
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Swern and Pinnick oxidations as illustrated in Scheme 21. 
 
Scheme 21: Synthesis of the acid fragment 84. 
Scheme 21: Reagents and Conditions: (a) (PPh3-CH3)+Br- , n-BuLi, 
THF, 0 oC to 50 oC, 3 h, 81%; (b) TEMPO, BAIB, CH2Cl2:H2O, r.t., 3 h, 
82% over two steps. 
Synthesis of the alcohol fragment 85: 
The synthesis of alcohol fragment 85 was achieved following seven 
synthetic sequences from the commercially available 1,8-octane diol 
(87) via Sharpless asymmetric resolution, Wittig olefination and LiAlH4 
 
Scheme 22: Synthesis of the alcohol fragment 85. 
Scheme 22: Reagents and conditions: (a) PMB-OH, Amberlyst-15, 
CH2Cl2, reflux, 5 h, 89%; (b) (i) (COCl)2, DMSO, Et3N, CH2Cl2, −78 oC, 
4 h; (ii) CH2=CHMgBr, THF, −20 oC, 3 h, 74% over two steps; (c) 
Ti(OiPr)4, (+)DIPT, TBHP, MS (4 Ǻ), CH2Cl2, 24 h, −23 oC, 43%; (d) 
MOMCl, i-Pr2EtN, 2 h, 0 oC, 85%; (e) DDQ, CH2Cl2:H2O (19:1), pH = 7 
buffer, rt, 1 h, 92%; (f) (i) DMP, CH2Cl2, 0 oC-r.t., 2 h; (ii) (PPh3-
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CH3)+Br- , n-BuLi, THF, −78 oC 3 h, 65%; (g) LiAlH4, THF, −10 to 0 oC, 
1 h, 79%. 
assisted region-selective epoxide opening as illustrated in Scheme 22. 
Completion of the total synthesis of aspergillide D (74):  
The total synthesis of aspergillide D (74) has been achieved by  
 
Scheme 23: Completion of the total synthesis of aspergillide D (74). 
Scheme 23: Reagents and Conditions: (a) 2,4,6-Cl3C6H2COCl, Et3N, 
DMAP, toluene, 65%; (b) Grubbs' 2nd generation catalyst, CH2Cl2, 
reflux, 10 h, 73%; (c) PtO2, H2, MeOH, 3 h, 81%; (d) (i) DIBAL-H,  
CH2Cl2, −78 oC, 15 min; (ii) Ph3P=CHCO2Et, benzene, reflux, 2 h, 61% 
over two steps; (e) LiOH, THF:H2O (3:2), reflux, 10 h, 77%; (f) MNBA, 
DMAP, toluene, r.t., 12 h, 66%; (g) (i) CuCl2.2H2O, CH3CN, r.t., 2 h, 
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70%; (ii) 4N HCl, THF, r.t., 6 h, 42%. 
following another seven step sequences from acid 84 and alcohol 85 
via Yamaguchi esterification, ring-closing metathesis, DIBAL-H 
mediated controlled reduction of lactone followed by Wittig olefination 
and Shiina macrolactonization reaction (Scheme 23). The protecting 
group of macrolactone core 81 was deproteced stepwise to complete 
the synthesis of aspergillide D (74). 
 
